Invasive aspergillosis among heart transplant recipients is rare but causes rapid death due to septic shock and multiple organ dysfunction syndrome

References

• Singh N, Husain S. Invasive aspergillosis in solid organ transplant recipients. Am J Transplant 2009;9(Suppl 4):S180–91.
   Google Scholar
• Munoz P, Rodriguez C, Bouza E, Palomo J, Yanez JF, Dominguez MJ, . Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis. Am J Transplant 2004;4:636–43.
   PubMed Web of Science ®Google Scholar
• Marty FM, Koo S. Role of (1-- > 3)-beta-d-glucan in the diagnosis of invasive aspergillosis. Med Mycol 2009;47(Suppl 1):S233–40.
   Google Scholar
• Luong ML, Clancy CJ, Vadnerkar A, Kwak EJ, Silveira FP, Wissel MC, . Comparison of a commercial Aspergillus real-time PCR assay with galactomannan testing of BAL fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. Clin Infect Dis 2011;52: 1218–26.
   PubMed Web of Science ®Google Scholar
• Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186:1297–306.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, . Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010;50:1101–11.
   PubMed Web of Science ®Google Scholar
• Montoya JG, Chaparro SV, Celis D, Cortes JA, Leung AN, Robbins RC, . Invasive aspergillosis in the setting of cardiac transplantation. Clin Infect Dis 2003;37(Suppl 3):S281–92.
   PubMed Web of Science ®Google Scholar
• Grossi P, Farina C, Fiocchi R, Dalla Gasperina D. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 2000;70:112–6.
   PubMed Web of Science ®Google Scholar
• Utili R, Zampino R, De Vivo F, Maiello C, Andreana A, Mormone G, . Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment. Clin Transplant 2000;14(4 Pt 1): 282–6.
   PubMed Web of Science ®Google Scholar
• Paniagua Martin MJ, Marzoa Rivas R, Barge Caballero E, Grille Cancela Z, Fernandez CJ, Solla M, . Efficacy and tolerance of different types of prophylaxis for prevention of early aspergillosis after heart transplantation. Transplant Proc 2010;42:3014–6.
   PubMed Web of Science ®Google Scholar
• Teuteberg JJ, Shullo M, Zomak R, McNamara D, McCurry K, Kormos RL. Aggressive steroid weaning after cardiac transplantation is possible without the additional risk of significant rejection. Clin Transplant 2008;22:730–7.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813–21.
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, . Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock:2008. Crit Care Med2008;36:296–327.
   PubMed Web of Science ®Google Scholar
• Chou NK, Chi NH, Wu IW, Huang SC, Chen YS, Yu HY, . Fungal infection in heart transplant recipients with severe sepsis: single-center experience. Transplant Proc 2010;42:952–4.
   PubMed Web of Science ®Google Scholar
• Munoz P, Alcala L, Sanchez Conde M, Palomo J, Yanez J, Pelaez T, . The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis. Transplantation 2003;75:326–9.
   PubMed Web of Science ®Google Scholar
• Gurwith MJ, Stinson EB, Remington JS. Aspergillus infection complicating cardiac transplantation. Report of five cases. Arch Intern Med 1971;128:541–5.
   PubMedGoogle Scholar
• Montoya JG, Giraldo LF, Efron B, Stinson EB, Gamberg P, Hunt S, . Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis 2001;33:629–40.
   PubMed Web of Science ®Google Scholar
• Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, . Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 2010;50:1559–67.
   PubMed Web of Science ®Google Scholar
• Kox WJ, Volk T, Kox SN, Volk HD. Immunomodulatory therapies in sepsis. Intensive Care Med 2000;26(Suppl 1):S124–8.
   Google Scholar
• Clancy CJ, Jaber RA, Leather HL, Wingard JR, Staley B, Wheat LJ, . Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol 2007;45:1759–65.
   PubMed Web of Science ®Google Scholar
• Nucci M, Nouer SA, Grazziutti M, Kumar NS, Barlogie B, Anaissie E. Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies. Clin Infect Dis 2010;51:1273–80.
   PubMed Web of Science ®Google Scholar